Brief: Novartis CEO Says 'Very Constructive' Engagement With Swiss Government Being Had On Finding Solution Around US MFN Policy
28/04/2026 07:06
April 28 (Reuters) - NOVARTIS AG NOVN.S: NOVARTIS CEO IN CALL - DISAPPOINTED BY GERMAN GOVERNMENT'S ANNOUNCEMENT TO CUT HEALTHCARE SYSTEM COSTS NOVARTIS CEO SAYS EARLY FOCUS IS TO LAUNCH RHAPSIDO IN GERMANY, JAPAN - MEDIA CALL NOVARTIS CEO SAYS LAUNCH OF ANTI-ALLERGY DRUG RHAPSIDO WILL NOT FULLY BE UNDER MFN POLICY NOVARTIS CEO SAYS WE ARE HAVING VERY CONSTRUCTIVE ENGAGEMENT WITH SWISS GOVERNMENT, TRYING TO FIND A SOLUTION GIVEN US MFN POLICY NOVARTIS CEO - NOT AWARE OF ANY SPECIFIC AGREEMENTS ON TARIFFS AND DRUG PRICING IN SWITZERLAND Further company coverage: NOVN.S
Recent news on Novartis AG
See all newsBrief: Novartis Remind Data At Eaaci Show Rhapsido Potential As First Targeted Therapy For Chronic Inducible Urticaria (Cindu)
Swiss stocks - Factors to watch on June 12
Swiss pharma hub Basel frets over population cap threat
Novartis says rare muscle disease drug shows promise in early trial
Live Markets: Europe at half-time: countdown to the ECB's 'insurance hike'